Status:
COMPLETED
Natural History Study in Subjects With Usher Syndrome
Lead Sponsor:
Fondazione Telethon
Conditions:
Usher Syndrome, Type 1B
Eligibility:
All Genders
8+ years
Brief Summary
Natural History Study in Subjects With Usher Syndrome ((USH1B) is a multi-centre, longitudinal, observational study designed to evaluate disease progression in subjects with USH1B by several vision-re...
Detailed Description
Natural History Study in Subjects With Usher Syndrome (USH1B) is being conducted to understand the progression of disease in USH1B patients as measured by visual acuity and visual field testing and a ...
Eligibility Criteria
Inclusion
- Must be willing to adhere to protocol for long-term follow-up as evidenced by written informed consent or parental permission and subject assent.
- Subjects diagnosed with USH1.
- Molecular diagnosis of USH1B due to MYO7A mutations (homozygotes or compound heterozygotes).
- Age eight years old or older at the time of baseline.
- Visual acuity ≥ 20/640 in at least one eye
Exclusion
- Unable or unwilling to meet requirements of the study.
- Unable to communicate with suitable verbal/auditory and/or tactile sign language (in the opinion of the investigator)
- Participation in a clinical study with an investigational drug in the past six months.
- Pre-existing eye conditions that would interfere with the interpretation of study endpoints (for example, glaucoma, corneal or significant lenticular opacities, cystoid macular oedema, macular hole).
- Complicating systemic diseases in which the disease itself, or the treatment for the disease, can alter ocular function. Examples are malignancies whose treatment could affect central nervous system function (for example, radiation treatment of the orbit; leukemia with CNS/optic nerve involvement). Also excluded would be subjects with immuno- compromising diseases, as there could be susceptibility to opportunistic infection \[such as cytomegalovirus (CMV) retinitis\].
- Subjects with diabetes or sickle cell disease would be excluded if they had any manifestation of advanced retinopathy (e.g. macular edema or proliferative changes).
- Prior ocular surgery within three months.
- Any other condition that would not allow the potential subject to complete follow-up examinations during the course of the study and, in the opinion of the investigator, makes the potential subject unsuitable for the study.
Key Trial Info
Start Date :
June 1 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 30 2022
Estimated Enrollment :
56 Patients enrolled
Trial Details
Trial ID
NCT03814499
Start Date
June 1 2018
End Date
December 30 2022
Last Update
December 9 2024
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Eye Clinic of the University of Campania Luigi Vanvitelli
Naples, Italy
2
Stichting Oogziekenhuis Rotterdam
Rotterdam, Netherlands
3
Instituto de Investigacion Sanitaria de la Fundacion Jimenez Diaz
Madrid, Spain